Advertisement
Advertisement

Finance

Goldman Sachs boasts fab new board diversity policy while underwriting IPO of a company with 100% male directors

Arcutis Biotherapeutics has 8 men on its board of directors and zero women
|  

Advertisement

Editor’s Picks

Advertisement

Trending

Advertisement

Trending